Table 5.
Treatment | P-value1 | |||||
---|---|---|---|---|---|---|
Fatty acids, % FAME | Control | LowDA | HighDA | SEM | L | Q |
C10 | 0.071 | 0.064 | 0.067 | 0.003 | 0.23 | 0.11 |
C12 | 0.068 | 0.064 | 0.065 | 0.003 | 0.39 | 0.52 |
C14 | 2.80 | 2.67 | 2.74 | 0.11 | 0.70 | 0.49 |
C14:1 t9 | 0.11 | 0.10 | 0.10 | 0.01 | 0.19 | 0.22 |
C14:1 c9 | 0.48 | 0.51 | 0.48 | 0.03 | 0.88 | 0.32 |
C15 | 0.50 | 0.49 | 0.51 | 0.02 | 0.68 | 0.58 |
C16 | 24.7 | 23.7 | 24.5 | 0.40 | 0.75 | 0.07 |
C16:1 c9 | 2.62 | 2.65 | 2.70 | 0.08 | 0.51 | 0.94 |
C17 | 1.81 | 1.86 | 1.89 | 0.06 | 0.34 | 0.90 |
C18 | 18.2 | 17.3 | 18.0 | 0.44 | 0.79 | 0.13 |
C18:1 t6-8 | 0.12 | 0.13 | 0.11 | 0.01 | 0.58 | 0.06 |
C18:1 t9 | 0.18 | 0.20 | 0.18 | 0.01 | 0.71 | 0.04 |
C18:1 t10 | 0.95 | 1.22 | 1.07 | 0.08 | 0.27 | 0.03 |
C18:1 t11 | 0.70 | 0.55 | 0.52 | 0.05 | 0.01 | 0.40 |
C18:1 c9 | 41.8 | 43.4 | 42.3 | 0.73 | 0.65 | 0.12 |
C18:1 c11 | 1.76 | 1.88 | 1.83 | 0.05 | 0.30 | 0.13 |
C18:2 c9c12 | 1.70 | 1.75 | 1.62 | 0.09 | 0.47 | 0.39 |
C20 | 0.12 | 0.11 | 0.11 | 0.004 | 0.41 | 0.26 |
C20:1 c11 | 0.30 | 0.36 | 0.32 | 0.02 | 0.52 | 0.09 |
C18:3 | 0.29 | 0.28 | 0.24 | 0.02 | 0.03 | 0.62 |
CLA c9t11 | 0.29 | 0.28 | 0.24 | 0.02 | 0.02 | 0.48 |
C20:4 | 0.32 | 0.29 | 0.30 | 0.02 | 0.66 | 0.56 |
C20:5 | 0.04 | 0.04 | 0.04 | 0.004 | 0.35 | 0.32 |
C22:5 | 0.15 | 0.14 | 0.14 | 0.01 | 0.61 | 0.71 |
SFA | 48.2 | 46.2 | 47.9 | 0.77 | 0.77 | 0.06 |
USFA | 51.8 | 53.8 | 52.2 | 0.77 | 0.77 | 0.06 |
MUFA | 49.0 | 51.0 | 49.6 | 0.75 | 0.61 | 0.06 |
PUFA | 2.80 | 2.78 | 2.58 | 0.13 | 0.24 | 0.57 |
CLA+TVA2 | 0.99 | 0.83 | 0.75 | 0.06 | 0.01 | 0.63 |
n-3FA | 0.49 | 0.46 | 0.42 | 0.03 | 0.11 | 0.92 |
n-6/n-3 | 4.33 | 4.62 | 4.64 | 0.22 | 0.32 | 0.63 |
MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
1L, linear effects; Q, quadratic effects.
2CLA + TVA, conjugated linoleic acid + trans-vaccenic acid.